These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34800352)

  • 41. 4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines.
    Lompardía SL; Díaz M; Papademetrio DL; Pibuel M; Álvarez É; Hajos SE
    Invest New Drugs; 2017 Feb; 35(1):1-10. PubMed ID: 27718039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells.
    Miyauchi Y; Yasuchika K; Fukumitsu K; Ishii T; Ogiso S; Minami T; Kojima H; Yamaoka R; Katayama H; Kawai T; Yoshitoshi-Uebayashi EY; Kita S; Yasuda K; Sasaki N; Uemoto S
    Sci Rep; 2017 Aug; 7(1):9827. PubMed ID: 28851916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
    Sureban SM; Madhoun MF; May R; Qu D; Ali N; Fazili J; Weygant N; Chandrakesan P; Ding K; Lightfoot SA; Houchen CW
    Oncotarget; 2015 Nov; 6(35):37200-15. PubMed ID: 26468984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.
    Yang Z; Zhuang L; Szatmary P; Wen L; Sun H; Lu Y; Xu Q; Chen X
    Int J Med Sci; 2015; 12(3):256-63. PubMed ID: 25798051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.
    Arechederra M; Bazai SK; Abdouni A; Sequera C; Mead TJ; Richelme S; Daian F; Audebert S; Dono R; Lozano A; Gregoire D; Hibner U; Allende DS; Apte SS; Maina F
    J Hepatol; 2021 Apr; 74(4):893-906. PubMed ID: 33197513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.
    Wang W; Huang P; Wu P; Kong R; Xu J; Zhang L; Yang Q; Xie Q; Zhang L; Zhou X; Chen L; Xie H; Zhou L; Zheng S
    Oncotarget; 2015 Aug; 6(24):20252-65. PubMed ID: 25970780
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
    Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma.
    Shi B; Abrams M; Sepp-Lorenzino L
    J Histochem Cytochem; 2013 Dec; 61(12):901-9. PubMed ID: 23979840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of hyaluronan synthases and involvement of T cell-derived hyaluronan in autoimmune responses to transplanted islets.
    Gebe JA; Gooden MD; Workman G; Nagy N; Bollyky PL; Wight TN; Vernon RB
    Matrix Biol Plus; 2021 Feb; 9():100052. PubMed ID: 33718858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of hyaluronan synthesis reduces versican and fibronectin levels in trabecular meshwork cells.
    Keller KE; Sun YY; Vranka JA; Hayashi L; Acott TS
    PLoS One; 2012; 7(11):e48523. PubMed ID: 23139787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
    Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK
    Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.
    Ramesh V; Selvarasu K; Pandian J; Myilsamy S; Shanmugasundaram C; Ganesan K
    Cell Oncol (Dordr); 2016 Dec; 39(6):523-536. PubMed ID: 27562587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.
    Yang YM; Wang Z; Matsuda M; Seki E
    Arch Pharm Res; 2021 Feb; 44(2):230-240. PubMed ID: 33486695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Systemic Hyaluronan Synthesis Exacerbates Murine Hepatic Carcinogenesis.
    Mikami K; Endo T; Sawada N; Igarashi GO; Kimura M; Sakuraba H; Fukuda S
    In Vivo; 2018; 32(2):273-278. PubMed ID: 29475909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
    Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.